Study Finds That CMS Methodology Likely Understates Puerto Rico's Medicare Advantage (MA) Benchmarks

SAN JUAN, Puerto Rico, Jan. 30, 2017 /PRNewswire/ --  A newly released study by The Moran Company, a Washington D.C. based health care research and consulting firm with extensive expertise in Medicare payment systems, has concluded that Puerto Rico's traditional Medicare (also known as fee-for-service) population is not representative of the island's much larger Medicare Advantage (MA) membership, questioning its use as the foundation for establishing MA benchmarks in Puerto Rico. 

"This study provides strong evidence to support the Puerto Rico healthcare community's longstanding call for administrative action by the Centers for Medicare and Medicaid Services (CMS) to adjust the benchmark so that it properly accounts for marked differences in size, composition and behavior between the island's Medicare Advantage and traditional Medicare populations," said Roberto García-Rodríguez, president of the Medicaid and Medicare Advantage Products Association of Puerto Rico (MMAPA) and CEO of Triple-S Management Corporation.

The report indicates that erosion in the fee-for-service (FFS) Medicare population, differences in characteristics and utilization patterns between Puerto Rico's MA and FFS populations, and certain anomalies in the data that CMS uses to calculate MA benchmarks in Puerto Rico―along with Medicare policies in Puerto Rico that differ from the mainland― create selection bias. "The net effect of differences in utilization and demographics for the two populations, historically depressed payment rates, and different Medicare services on the island compared to the U.S., leads to the conclusion that the FFS utilization under-estimates MA benchmarks," the study asserts. The study further concludes that the nature of the resulting selection bias may understate the Puerto Rico benchmarks to the point where "it will be increasingly difficult for the MA plans serving these populations to provide the level of service needed."

Puerto Rico's 2014 FFS enrollees who have both Parts A and B, which is the population used to set MA benchmarks, accounted for only 12% of the total eligible population, and has a much smaller proportion of dual eligible beneficiaries (10%) than the MA population (50%).  This is markedly different from the rest of the nation. 

Puerto Rico is also unique across the nation in that MA enrollment exceeds 75% of the Medicare-eligible population (compared with a national average of 32%) and has been increasing every year, with 30% of Puerto Rico's FFS population switching to MA annually (compared with a national average switch rate of 3-5%).  

Utilization patterns between the populations are also quite distinct, suggesting access issues and differences in severity of illnesses that are not corrected by risk adjustment.  Lastly, historical differences in how the Medicare program applies in Puerto Rico compared to the mainland (e.g., Part D low-income subsidies are not available and partial dual status does not exist in Puerto Rico) depress historical FFS costs on the island. As noted in the study, "If FFS beneficiaries are experiencing access to care barriers to getting the services they need, this will depress MA benchmarks and perpetuate inadequacies in the PR health care system, already challenged by depressed wages for health care workers and out-migration from the island."

The MA benchmark in Puerto Rico, a national outlier, is currently $473 per beneficiary, or 43% below the U.S. average of $830, 38% below the state with the next lowest benchmark, and 26% below the U.S. Virgin Islands, another U.S. territory located less than 80 miles from San Juan.

CMS establishes MA benchmarks for counties across the nation based on the cost of serving the corresponding FFS population.  Its benchmark methodology assumes that FFS utilization is generally representative of MA utilization, and existing risk adjustment models are not designed to correct for selection bias. The assumption underlying this statutory requirement is that MA costs should not exceed that of the average FFS beneficiary. 

Selection bias is increasingly likely, however, as the FFS population decreases, and at a certain MA penetration level, the methodology begins to break down.  As the study points out, "the MA program relies upon risk adjustment to standardize benchmark calculations, but such reliance depends on the stability of the population and its size.  The risk adjustment model is less reliable as the size of the population decreases and as it varies in ways not accounted for in the model.  Both of these issues are prominent in Puerto Rico." 

CMS has no methodology to examine high MA penetration jurisdictions in order to evaluate the viability of its methods. According to the study, however, CMS has the authority to adjust its methodologies consistent with the overall intent of the statute, and should consider ways to correct the bias and establish a proper MA benchmark for Puerto Rico.

"Our commitment to future generations is to continually call on local and federal government leaders to unite on behalf of the Puerto Rico healthcare system and demand justice from CMS in its funding of the Medicare Advantage program for Puerto Rico's 570,000 beneficiaries. Permanent funding solutions are necessary to stabilize the Puerto Rico healthcare delivery system, which in turn is a necessary infrastructure component of Puerto Rico's economic recovery.  Everyone needs quality healthcare," stated Jim O'Drobinak, MMAPA Board member and CEO of MCS. 

Broader policy questions on methodology as MA penetration rates increase in U.S.

Importantly, the study is also a harbinger of what other U.S. jurisdictions with increasing MA penetration will face. "While Puerto Rico represents an outlier in its high rate of MA enrollment, it is likely that there are or will be U.S. counties that approach similar levels of MA enrollment, raising the question of how and when to evaluate the representativeness of a FFS population as the basis for accurately estimating MA benchmarks," the study indicates. 

"This study provides conclusive evidence that selection bias occurs when MA penetration reaches a tipping point, and has important policy implications," indicated Dr. Rick Shinto, MMAPA member and CEO of MMM Healthcare, LLC.  "Puerto Rico is the canary in the coal mine, and can serve as a case study for HHS and CMS to evaluate new policies and methodologies that adjust for a high probability of selection bias in counties with large MA enrollments. As MA penetration continues to increase across the United States, this need will also increase. We invite policymakers to work with the Puerto Rico healthcare community to find a better way―with the proper level of funding―to provide quality care to our senior citizens," added Dr. Shinto.

Call for action as funds dwindle and healthcare system is in dire straits

By the end of 2017, Puerto Rico will have lost approximately $4 billion in aggregate MA funding since 2011. These funding cuts have already resulted in substantial benefit reductions and increased pressures to reduce provider compensation, which has contributed to the loss of over 3,000 physicians to the United States mainland since cuts associated with the Affordable Care Act began.

"The Moran Company study strongly supports MMAPA's call in Washington D.C. for innovative policy solutions that address Puerto Rico's deteriorating healthcare delivery system, which directly impacts more than 570,000 of Puerto Rico's senior citizens," said García-Rodriguez. He added, "We need CMS to act now and adjust its methodology."

There is increasing awareness of the need to address this disparity as evidenced by the letter that 16 members of Congress from both parties sent on January 27, 2017 to CMS and the U.S. Department of Health and Human Services (HHS). In the letter, they echo a recommendation issued last December by the Congressional Task Force on Economic Growth for Puerto Rico, which stated the need "to ensure that MA plans, including those in Puerto Rico, are being fairly and property compensated for the services they provide to beneficiaries.'"

Likewise, the Governor of Puerto Rico requested the support of the Acting Secretary of HHS and Acting Administrator of CMS in a January 25, 2017 letter to consider Puerto Rico's unique situation in the Advance Notice and Draft Call Letter for 2018, expected to be issued February 1, 2017. He also created a private-public group representing a broad cross section of the healthcare community to continue to address disparities in Medicare and Medicaid funding in Puerto Rico.

These letters, as well as the Moran study, build on an Issue Brief released in December by HHS's Office of the Assistant Secretary for Planning and Evaluation (ASPE) that highlights the challenges facing Puerto Rico's healthcare system and the need for supporting data.

 A full copy of the Moran study, the letters from members of Congress and the Governor, and the ASPE Issue Brief are available at the MMAPA website, www.mmapapr.org.

About MMAPA

The Medicaid and Medicare Advantage Products Association of Puerto Rico (www.mmapapr.org) is a non-for-profit association comprised of the leading Medicaid and Medicare Advantage organizations in Puerto Rico: First Medical, Humana, MCS, MMM/PMC, Molina Healthcare and Triple-S. This association was established in 2009 to evaluate and act on the implications of new government policy on funding for Puerto Rico's healthcare system.

SOURCE Medicaid and Medicare Advantage Products Association of Puerto Rico

Related Links

http://www.mmapapr.org